Questions remain on whether there are links between patients with asthma and RA, including heterogeneity of disease.

AstraZeneca has recently completed a significant clinical study titled ‘A Multicenter, Single-arm, Open-label, Post-Authorization, Phase 4 Effectiveness and Safety Study of Tezepelumab in Adult and ...

If you are wheezing, coughing, or having extreme shortness of breath, you may be having an asthma attack.

A new way to treat asthma symptoms and even repair previously irreversible lung damage could be on the horizon following the ...

For many years, treatment of asthma has focused on symptom management and control. As the understanding of disease processes has improved and treatments begin to target underlying mechanisms, there is ...

Patients with severe asthma receiving mepolizumab experience reductions in healthcare resource use and improvements in work ...

The ultra-long acting investigational biologic is administered once every 6 months as a subcutaneous injection. Depemokimab reduced the rate of exacerbations in patients with severe asthma with type 2 ...

The ATHENA Study, officially titled ‘ItAlian, Multicenter, Observational, Prospective sTudy to Evaluate the acHievement of Clinical rEmission and immuNomodulation in Severe Eosinophilic Asthma ...

Blood eosinophil count and fractional exhaled nitric oxide (FeNO) play an important role in selecting biological therapies for severe asthma. This analysis of patient-level data pooled across 22 ...